UK MHRA: Gene Therapy Manufacturing Methods Need ‘Urgent Harmonization’

 
• By Eliza Slawther
  
Caption CRISPR-Cas9 gene editing poses a major safety concern for regulators (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies